Evelo Biosciences Inc (EVLO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: EVLO Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-11-08 2023-11-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
3,103 -15.4%
0.33
1,024 USD 		3,103 -15.4% 0.33 1,024 USD
2023-11-08 2023-11-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
3,163 -10.9%
0.33
1,044 USD 		3,163 -10.9% 0.33 1,044 USD
2023-11-08 2023-11-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
1,811 -7.5%
0.33
598 USD 		1,811 -7.5% 0.33 598 USD
2023-11-08 2023-11-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
172 -1.0%
0.33
57 USD 		172 -1.0% 0.33 57 USD
2023-11-03 2023-11-02 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
3,999 -18.5%
0.33
1,320 USD 		3,999 -18.5% 0.33 1,320 USD
2023-11-03 2023-11-02 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
6,854 -23.5%
0.33
2,262 USD 		6,854 -23.5% 0.33 2,262 USD
2023-11-03 2023-11-02 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
6,854 -33.5%
0.33
2,262 USD 		6,854 -33.5% 0.33 2,262 USD
2023-09-29 2023-09-28 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
1,996 -10.6%
3.94
7,864 USD 		1,996 -10.6% 3.94 7,864 USD
2023-08-09 2023-08-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
2,004 -18.1%
9.51
19,058 USD 		2,004 -18.1% 9.51 19,058 USD
2023-08-09 2023-08-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
342 -8.3%
9.51
3,252 USD 		342 -8.3% 9.51 3,252 USD
2023-08-09 2023-08-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
3,128 -15.8%
9.51
29,747 USD 		3,128 -15.8% 9.51 29,747 USD
2023-08-09 2023-08-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
3,434 -30.2%
9.51
32,657 USD 		3,434 -30.2% 9.51 32,657 USD
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
3,246,753 +474.0%
2.31
7,499,999 USD 		3,246,753 +474.0% 2.31 7,499,999 USD
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,082,251 +263.3%
2.31
2,500,000 USD 		1,082,251 +263.3% 2.31 2,500,000 USD
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,082,251 +285.1%
2.31
2,500,000 USD 		1,082,251 +285.1% 2.31 2,500,000 USD
2023-06-12 2023-05-23 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
22,571 -7.9%
0.14
3,201 USD 		22,571 -7.9% 0.14 3,201 USD
2023-05-10 2023-05-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
38,531 -29.6%
0.13
4,836 USD 		38,531 -29.6% 0.13 4,836 USD
2023-05-10 2023-05-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
68,014 -19.3%
0.13
8,536 USD 		68,014 -19.3% 0.13 8,536 USD
2023-05-10 2023-05-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
3,537 -5.7%
0.13
444 USD 		3,537 -5.7% 0.13 444 USD
2023-05-10 2023-05-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
66,730 -40.6%
0.13
8,375 USD 		66,730 -40.6% 0.13 8,375 USD
2023-01-23 2023-01-23 S Sale

CARRIERE STEPHEN J

Principal Accounting Officer

Officer
151 -42.7%
1.06
160 USD 		151 -42.7% 1.06 160 USD
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
13,698,630 +inf%
1.46
20,000,000 USD 		13,698,630 +inf% 1.46 20,000,000 USD
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
6,849,315 +499.8%
1.46
10,000,000 USD 		6,849,315 +499.8% 1.46 10,000,000 USD
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,369,863 +33.2%
1.46
2,000,000 USD 		1,369,863 +33.2% 1.46 2,000,000 USD
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,095,890 +138.5%
1.46
1,599,999 USD 		1,095,890 +138.5% 1.46 1,599,999 USD
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
4,383,561 +136.7%
1.46
6,399,999 USD 		4,383,561 +136.7% 1.46 6,399,999 USD
2022-05-31 2022-05-27 B Purchase

Darzi Lord Ara

Non-Executive Director
342,465 +inf%
1.46
499,999 USD 		342,465 +inf% 1.46 499,999 USD
2022-05-31 2022-05-27 B Purchase

McHale Duncan

Chief Medical Officer

Officer
34,246 +inf%
1.46
49,999 USD 		34,246 +inf% 1.46 49,999 USD
2022-05-31 2022-05-27 B Purchase

Epstein David R

Non-Executive Director
17,123 +25.6%
1.46
25,000 USD 		17,123 +25.6% 1.46 25,000 USD
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
46,429 +1.1%
15.00
696,435 USD 		46,429 +1.1% 15.00 696,435 USD
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
37,143 +2.8%
15.00
557,145 USD 		37,143 +2.8% 15.00 557,145 USD
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
9,285 +1.2%
15.00
139,275 USD 		9,285 +1.2% 15.00 139,275 USD
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
37,143 +1.2%
15.00
557,145 USD 		37,143 +1.2% 15.00 557,145 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
200 +1.1%
7.02
1,404 USD 		200 +1.1% 7.02 1,404 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
500 +2.9%
6.98
3,490 USD 		500 +2.9% 6.98 3,490 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
1,000 +6.2%
6.91
6,910 USD 		1,000 +6.2% 6.91 6,910 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
800 +5.3%
7.16
5,728 USD 		800 +5.3% 7.16 5,728 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
4,970 +48.6%
6.49
32,255 USD 		4,970 +48.6% 6.49 32,255 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
30 +0.3%
6.45
194 USD 		30 +0.3% 6.45 194 USD
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
200 +2.0%
6.40
1,280 USD 		200 +2.0% 6.40 1,280 USD
2020-12-02 2020-12-01 S Sale

Liu Xiaoli Jacqueline

Principal Accounting Officer

Officer
3,000 -100.0%
5.17
15,510 USD 		3,000 -100.0% 5.17 15,510 USD
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +11.1%
4.58
4,580 USD 		1,000 +11.1% 4.58 4,580 USD
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +12.5%
4.48
4,480 USD 		1,000 +12.5% 4.48 4,480 USD
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +14.3%
4.47
4,470 USD 		1,000 +14.3% 4.47 4,470 USD
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
2,752 +64.8%
4.46
12,274 USD 		2,752 +64.8% 4.46 12,274 USD
2020-09-01 2020-08-28 B Purchase

Epstein David R

Non-Executive Director
3,248 +324.8%
4.40
14,291 USD 		3,248 +324.8% 4.40 14,291 USD
2020-09-01 2020-08-28 B Purchase

Epstein David R

Non-Executive Director
1,000 +inf%
4.34
4,340 USD 		1,000 +inf% 4.34 4,340 USD
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,666,667 +69.1%
3.75
6,250,001 USD 		1,666,667 +69.1% 3.75 6,250,001 USD
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,333,333 +inf%
3.75
4,999,999 USD 		1,333,333 +inf% 3.75 4,999,999 USD
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
333,333 +74.3%
3.75
1,249,999 USD 		333,333 +74.3% 3.75 1,249,999 USD
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,333,333 +72.6%
3.75
4,999,999 USD 		1,333,333 +72.6% 3.75 4,999,999 USD
2018-05-15 2018-05-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
281,250 +1.6%
16.00
4,500,000 USD 		281,250 +1.6% 16.00 4,500,000 USD
2018-05-15 2018-05-11 B Purchase

Flagship Ventures Fund V General Partner LLC

Major owner
281,250 +1.6%
16.00
4,500,000 USD 		281,250 +1.6% 16.00 4,500,000 USD